Anji Pharma Revenue and Competitors

Boston, MA USA

Location

$105M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Anji Pharma's estimated annual revenue is currently $1.2M per year.(i)
  • Anji Pharma's estimated revenue per employee is $100,500
  • Anji Pharma's total funding is $105M.

Employee Data

  • Anji Pharma has 12 Employees.(i)
  • Anji Pharma grew their employee count by -45% last year.

Anji Pharma's People

NameTitleEmail/Phone
1
Head Regulatory AffairsReveal Email/Phone
2
Head Clinical OperationsReveal Email/Phone
3
Head CMCReveal Email/Phone
4
Director, Global Strategic Operations and Alliance ManagementReveal Email/Phone
5
Chief Scientific OfficerReveal Email/Phone
6
Medical DirectorReveal Email/Phone
7
Chief Operating OfficerReveal Email/Phone
8
Global Head DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$413.3M3400%$634MN/A
#2
$57.9M2880%N/AN/A
#3
$2M10-17%N/AN/A
#4
$33.6M16720%N/AN/A
#5
$15.5M77126%N/AN/A
#6
$25.1M1258%$113MN/A
#7
$0.3M30%N/AN/A
#8
$10.1M50-2%N/AN/A
#9
$1.8M385-4%$538MN/A
#10
$46.6M232-7%N/AN/A
Add Company

What Is Anji Pharma?

Anji Pharma is a global pharmaceutical company focused on tackling high-value targets validated by human genetics. We are exhaustive in our discovery and clinical efforts while nimble in our strategy and execution. We have assembled a world-class team of scientist entrepreneurs who are committed to accelerate innovative medicines in China and worldwide.

keywords:N/A

$105M

Total Funding

12

Number of Employees

$1.2M

Revenue (est)

-45%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Anji Pharma News

2022-03-22 - Peptide Therapeutics: Contract API Manufacturing Market ...

As pharma companies resume full-scale operation after the COVID-19 outbreak, ... AnGes; Anji Pharmaceuticals; Antagene; APAC Pharmaceutical...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.1M12-25%N/A
#2
$1.8M12N/AN/A
#3
$1.8M12-8%$1M
#4
$2.9M120%N/A
#5
$1.5M120%N/A